Related Articles

• Cystatin B as a potential diagnostic biomarker in ovarian clear cell carcinoma
• Toward an understanding of the pathophysiology of clear cell carcinoma of the ovary (Review)
• Molecular pathogenesis of endometriosis-associated clear cell carcinoma of the ovary (Review)
• Candidate synthetic lethality partners to PARP inhibitors in the treatment of ovarian clear cell cancer (Review)
• Modulation of estrogenic action in clear cell carcinoma of the ovary (Review)